personally I think the discussion should be more focused on the company pathway for the next:
1 month - results
3 months - digestion of results
6+ months - decision time regarding the results.
I feel talk about what $$ everyone is after really doesnt help shape any meaningful thought.
However, discussions of what Neuren will be doing over the next 6 months will be the main factor that determines any price...for better or worse.
Like a lot here, ive been invested for 7+ years and for me its all been leading up to PhII value for NNZ - Ive always thought (and continue to now) that Neuren just cant/wont continue further down this path.
IMO once they have demonstrated the potential of the drug - ie the PhII results for these 4 indications - I feel we will all know the fate of Neuren.
As usual, good luck to holders !
Ann: 2023 Annual Report to shareholders, page-182
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.72 |
Change
-0.240(1.15%) |
Mkt cap ! $2.645B | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.21 | $20.31 | $15.80M | 766.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $20.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.72 | 3108 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.75 |
Change
-0.240 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $20.97 | $21.15 | $20.32 | 199599 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| NEU (ASX) Chart |